EN DE
STOCK COMPARISON

Metro Healthcare Berhad vs HCA Healthcare: Fair Value & Quality

Both stocks run through our valuation models. Here is how Metro Healthcare Berhad (0329) and HCA Healthcare (HCA) compare, as of Sep 25, 2026.

As of Sep 25, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Metro Healthcare Berhad trades at MYR 0.22 versus a fair value of MYR 0.13 (-40%), while HCA Healthcare trades at $436 versus $593 (+36%).
Metro Healthcare Berhad
0329.KLSE · MYR · Consumer Discretionary
-40%
upside to fair value
overvalued
PriceMYR 0.22
Fair ValueMYR 0.13
Quality56/100
HCA Healthcare
HCA · USD · Health Care
+36%
upside to fair value
undervalued
Price$436
Fair Value$593
Quality70/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Metro Healthcare BerhadHCA Healthcare
Valuation
21.5×P/E (TTM)15.0×
1.02×P/S (TTM)1.32×
0.69×P/BNegative equity
n/aEV/EBITDA9.1×
n/aPEG1.18×
−39.5%Fair value upside+35.8%
2.3%Dividend yield0.7%
MYR 0.01Dividend per share$2.94
Profitability
12%Operating margin15%
0.65×EBIT margin trend (5Y)1.12×
9%Return on equityNegative equity
5%Return on assets12%
Growth
1%Revenue growth (YoY)4%
7.8%Avg. growth/yr (3Y)7.9%
n/aAvg. growth/yr (5Y)8.0%
−9.9%Value creation/yr+16.7%
Balance & size
11.2×Interest coverage (EBIT/interest)5.3×
n/aDebt / equityNegative equity
$52MMarket cap$101B
mixedGrowth qualityhealthy
Valuation multiples (P/E, P/S, P/B, EV/EBITDA) are shown but not scored here: the two companies sit in different sectors, and multiples only compare fairly between similar business models. PEG stays scored, as it relates the P/E to growth.

HCA Healthcare leads: 2 to 7 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Metro Healthcare Berhadof which business quality 59 · market factors 47 HCA Healthcareof which business quality 66 · market factors 47
ProfitabilityMargins and returns on capital today
42
76
Quality GrowthAre margins and returns improving?
46
61
CashflowEarnings quality: real cash, not paper profit
71
62
Fin. StrengthBalance sheet, leverage, solvency risk
93
39
InvestmentDisciplined investing over empire-building
32
75
Low VolatilityCalm price path (market factor)
76
58
MomentumPrice trend over the last 3–12 months (market factor)
38
44
52W MomentumDistance to the 52-week high (market factor)
30
42
Net IssuanceShare count: buybacks or dilution?
50
100

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyMetro Healthcare BerhadPrice MYR 0.22HCA HealthcarePrice $436
DCF Models-14%close to the priceMYR 0.19+41%above the price$615
Earnings-Based-67%below the priceMYR 0.07-34%below the price$289
Dividend Discountn/a-88%below the price$53.85
Multiples-44%below the priceMYR 0.12+54%above the price$673
Asset-Based-77%below the priceMYR 0.05n/a
Growth DCF-28%below the priceMYR 0.16+47%above the price$643
Economic Profit-56%below the priceMYR 0.10-4%close to the price$419
Growth Earnings-49%below the priceMYR 0.11+16%above the price$506
Minimum-77%below the priceMYR 0.05-88%below the price$53.85
Maximum-14%close to the priceMYR 0.19+54%above the price$673
Median-49%below the priceMYR 0.11+16%above the price$506
Geometric mean-52%below the priceMYR 0.10-16%below the price$366

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Metro Healthcare Berhad: 23 of 24 models see the stock below the current price.

HCA Healthcare: 6 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Metro Healthcare Berhad
Price MYR 0.22
Fair Value MYR 0.13
Bear MYR 0.10Bull MYR 0.16
HCA Healthcare
Price $436
Fair Value $593
Bear $306Bull $841

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Metro Healthcare Berhad · Consumer Discretionary

Quality score56 · above median
Fair value upside-40% · below median

HCA Healthcare · Health Care

Quality score70 · Top 25%
Fair value upside+36% · Top 25%

Bottom line

As of Sep 25, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Metro Healthcare Berhad trades at MYR 0.22 versus a fair value of MYR 0.13 (-40%), while HCA Healthcare trades at $436 versus $593 (+36%).

HCA Healthcare has the higher quality score (70/100).

Open HCA Healthcare live analysis →
Metro Healthcare Berhad · HCA Healthcare

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Metro Healthcare Berhad

Amazon.com vs Sony GroupAmazon.com vs Booking HoldingsMicrosoft vs NvidiaApple vs Microsoft

Related to HCA Healthcare

Nvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor ManufacturingAlphabet Inc Class C vs Meta PlatformsCisco Systems vs Nvidia
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.